Lupin Ltd - ESG Rating & Company Profile powered by AI
The Disclosure score includes 17 UN Sustainable Development Goals including: 'No Poverty', 'Climate Action' and 'Peace, Justice & Strong Institutions'. The SDG score for Lupin Ltd represents its reporting of the United Nations Sustainable Development Goals. Other companies in the scoring peer group for Lupin Ltd are shownin the table.
Lupin Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Lupin Ltd | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Lupin Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Lupin Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Lupin Ltd report the average age of the workforce?
Sign up for free to unlockDoes Lupin Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Lupin Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Lupin Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Lupin Ltd offer flexible work?
Sign up for free to unlockDoes Lupin Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Lupin Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Lupin Ltd conduct supply chain audits?
Sign up for free to unlockDoes Lupin Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Lupin Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Lupin Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Lupin Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Lupin Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Lupin Ltd disclose water use targets?
Sign up for free to unlockDoes Lupin Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Lupin Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Lupin Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Lupin Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Lupin Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Lupin Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Lupin Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Lupin Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Lupin Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Lupin Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Lupin Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Lupin Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Lupin Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Lupin Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Lupin Ltd disclose its waste policy?
Sign up for free to unlockDoes Lupin Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Lupin Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Lupin Ltd disclose energy use targets?
Sign up for free to unlockDoes Lupin Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Lupin Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Lupin Ltd
These potential risks are based on the size, segment and geographies of the company.
Lupin Limited, a pharmaceutical company, manufactures and distributes a range of branded and generic formulations, biotechnology products, active pharmaceutical ingredients, and specialty products in India, the United States, Japan, and internationally. The company offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastro-intestinal, anti-infective, non-steroidal anti-inflammatory drug therapy, anti-TB, and cephalosporin. It also develops and commercializes various drug delivery platforms; and provides biosimilar products. In addition, the company engages in the provision of the over-the-counter products, and contract manufacturing and supply services; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. Lupin Limited has a licensing, development, and commercialization agreement with Boehringer Ingelheim for Lupin's MEK inhibitor compound (LNP3794) as a potential targeted therapy for patients with cancers. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001 as a result of its amalgamation with Lupin Laboratories Limited. Lupin Limited was founded in 1968 and is based in Mumbai, India.